open access
The assessment of testosterone and radioisotopic index of bone metabolism and bone mineral density in men with testosterone deficiency after one year of testosterone therapy
- Department of Radiological and Isotopic Diagnosis and Therapy, Medical University of Lodz, 113 Zeromskiego Street, 90-549 Lodz, Poland
- Department Of Endocrinology and Radioisotope Therapy , Military Institute of Medicine,, 128 Szaserow Street, 04-141 Warsaw, Poland
- Department of Neurosurgery and Peripheral Nerves Surgery of Medical University of Lodz,, 113 Zeromskiego Street, 90-549 Lodz, Poland
open access
Abstract
Abstract
Keywords
testosterone, bone metabolism, densitometry
Title
The assessment of testosterone and radioisotopic index of bone metabolism and bone mineral density in men with testosterone deficiency after one year of testosterone therapy
Journal
Issue
Article type
Research paper
Pages
14-19
Published online
2017-09-21
Page views
3441
Article views/downloads
1600
DOI
Pubmed
Bibliographic record
Nucl. Med. Rev 2018;21(1):14-19.
Keywords
testosterone
bone metabolism
densitometry
Authors
Wieslaw Tryniszewski
Grzegorz Kamiński
Zbigniew Maziarz
Michal Nowak
Mariusz Gadzicki
Maciej Radek
- Marek M. Leczenie testosteronem. MedPharma Polska 2013.
- Zgliczyński S, Rabijewski M, Wiktorowicz-Dudek A. Wskaźnik andropauzy w rozpoznawaniu i leczeniu ujawniającego się z wiekiem hipogonadyzmu. Endokrynologia Polska. 2003; 2(54): 148–154.
- Torremadé-Barreda J, Rodríguez-Tolrà J, Román-Romera I, et al. [Testosterone-deficiency as a risk factor for hip fracture in eldery men]. Actas Urol Esp. 2013; 37(3): 142–146.
- Kang HY, Cho CL, Huang KL, et al. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. J Bone Miner Res. 2004; 19(7): 1181–1190.
- Balkan W, Burnstein KL, Schiller PC, et al. Androgen-induced mineralization by MC3T3-E1 osteoblastic cells reveals a critical window of hormone responsiveness. Biochem Biophys Res Commun. 2005; 328(3): 783–789.
- Wiren KM, Chapman Evans A, Zhang XW. Osteoblast differentiation influences androgen and estrogen receptor-alpha and -beta expression. J Endocrinol. 2002; 175(3): 683–694.
- Chen Q, Kaji H, Sugimoto T, et al. Testosterone inhibits osteoclast formation stimulated by parathyroid hormone through androgen receptor. FEBS Lett. 2001; 491(1-2): 91–93.
- Tryniszewski W, Maziarz Z, Kulińska M. Przydatność scyntygraficznej oceny jakości i metabolizmu tkanki kostnej u osób z osteoporozą. Endokrynol Pol. 2005; 56(4): 483.
- Tryniszewski W, Gadzicki M, Maziarz Z. Wykorzystanie własnego programu i metody scyntygrafii dynamicznej i statycznej kości do matematycznej analizy metabolizmu kostnego i porównanie z gęstością mineralną kości w aspekcie ich przydatności klinicznej. Kwartalnik Ortopedyczny. 2006; 4: 296.
- Tryniszewski W, Gadzicki M, Rysz J, et al. The behaviour of bone mineral density and bone metabolism index in young and menopausal women with the consideration of body mass index. Med Sci Monit. 2010; 16(7): 342–347.
- Tryniszewski W, Sobczuk A, Górska-Chrząstek M. The assessment of indicator of bone metabolism (IBM) and designation of its normal values range in healthy women and men. Przegląd Menopauzalny. 2011; 1(53): 50–57.
- Wang C, Swerdloff RS, Iranmanesh A, et al. Testosterone Gel Study Group. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000; 85(8): 2839–2853.
- Chin KY, Ima-Nirwana S. Sex Steroids and Bone Health Status in Men. International Journal of Endocrinology. 2012; 2012: 1–7.
- Kung AWC. Androgen and bone mass in men. Asian J Androl. 2003; 5(2): 148–154.
- Travison TG, Araujo AB, Kupelian V, et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2007; 92(2): 549–555.
- Aversa A, Bruzziches R, Francomano D, et al. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study. Aging Male. 2012; 15(2): 96–102.
- Kok-Yong C, Soelaiman IN. Sex Steroids and Bone Health Status in Men. International Journal of Endocrinology. 2012; 2012: 1–7.
- Ramin S, Seyed RZ, Masrour G, et al. Age-related changes in skull uptake on bone scintigraphy: a quantitative study. Nuc Med Rev. 2008; 11(2): 67–69.
- Szulc P, Uusi-Rasi K, Claustrat B, et al. Role of sex steroids in the regulation of bone morphology in men. The MINOS study. Osteoporos Int. 2004; 15(11): 909–917.